G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 73 filers reported holding G1 THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,454 | -74.9% | 12,815 | -53.3% | 0.00% | – |
Q1 2023 | $73,579 | -72.5% | 27,455 | -44.3% | 0.00% | -100.0% |
Q4 2022 | $267,775 | -55.5% | 49,314 | +2.4% | 0.00% | -66.7% |
Q3 2022 | $602,000 | +484.5% | 48,181 | +130.2% | 0.00% | +200.0% |
Q2 2022 | $103,000 | +9.6% | 20,926 | +69.9% | 0.00% | – |
Q1 2022 | $94,000 | -38.2% | 12,319 | -17.0% | 0.00% | – |
Q4 2021 | $152,000 | -25.9% | 14,839 | +59.0% | 0.00% | -100.0% |
Q2 2021 | $205,000 | -4.2% | 9,332 | -21.7% | 0.00% | -50.0% |
Q4 2020 | $214,000 | -82.3% | 11,919 | -88.6% | 0.00% | -87.5% |
Q3 2020 | $1,207,000 | +135.3% | 104,468 | +393.7% | 0.02% | +100.0% |
Q2 2020 | $513,000 | -15.5% | 21,160 | -61.6% | 0.01% | -50.0% |
Q1 2020 | $607,000 | +17.0% | 55,084 | +180.8% | 0.02% | +433.3% |
Q4 2019 | $519,000 | -30.7% | 19,618 | -40.3% | 0.00% | -57.1% |
Q3 2019 | $749,000 | +258.4% | 32,871 | +383.1% | 0.01% | +250.0% |
Q2 2019 | $209,000 | -82.5% | 6,804 | -89.1% | 0.00% | -85.7% |
Q4 2018 | $1,192,000 | -25.8% | 62,233 | +102.5% | 0.01% | -26.3% |
Q3 2018 | $1,607,000 | +102.1% | 30,735 | +68.0% | 0.02% | +72.7% |
Q2 2018 | $795,000 | – | 18,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
RA Capital Management | 363,051 | $6,027,000 | 0.26% |
BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |